This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy.
AMA J Ethics. 2023; 25(6):E386-390. doi:
10.1001/amajethics.2023.386.
Kelsey Mumford, Lin Fraser, EdD, and Gail Knudson, MD, MEd
While transgender health care has moved beyond “gender identity disorder” and “gender dysphoria” as mental illnesses, gender incongruence continues to be a source of oppression.
AMA J Ethics. 2023; 25(6):E446-451. doi:
10.1001/amajethics.2023.446.
Diagnostic utility of weight and body mass index is widely overestimated, and their use as health and wellness measures can be sources of iatrogenic harm.
AMA J Ethics. 2023; 25(7):E540-544. doi:
10.1001/amajethics.2023.540.
While useful in analyzing population trends in relative body weight, BMI possesses multiple shortcomings when used as an individualized health screening tool.
AMA J Ethics. 2023; 25(7):E545-549. doi:
10.1001/amajethics.2023.545.
Dr Eric Plemons joins Ethics Talk to discuss facial feminization surgery and how clinicians can best support patient decisions about gender-affirming care.
Dr Laura Kolbe joins Ethics Talk to discuss her article, coauthored with Drs Ryan H. Nelson, Joelle Robertson-Preidler, Olivia Schuman, and Inmaculada de Melo-Martín: “Is a Video Worth a Thousand Words?”
Dr Kristen R. Choi joins Ethics Talk to discuss her article, coauthored with Bantale Ayisire: “When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered?”